Table of Content

Part 1. Summary
Part 2. Introduction
? Study period
? Geographical scope
? Market segmentation
Part 3. Emerging therapeutics for hematological malignancies market overview
Part 4. Market breakdown by type
? CAR T-cell therapies
? Monoclonal antibodies
Part 5. Market breakdown by indication
? Leukemia
? Lymphoma
? Multiple myeloma
Part 6. Market breakdown by region
? Asia Pacific
? Europe
? North America
? Rest of the World (RoW)
Part 7. Key companies
? AbbVie Inc.
? Amgen Inc.
? Bristol-Myers Squibb Company (BMS)
? F. Hoffmann-La Roche AG
? Gilead Sciences, Inc.
? GlaxoSmithKline plc
? Immune-Onc Therapeutics, Inc.
? Johnson & Johnson
? Merck & Co., Inc.
? Novartis AG
? Pfizer Inc.
? Sanofi S.A.
? Takeda Pharmaceutical Company Limited
Part 8. Methodology